Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

BACKGROUND: Failure of locoregional control is the main cause of recurrence in advanced head and neck cancer. This multi-center trial aims to improve outcome in two ways. Firstly, by redistribution of the radiation dose to the metabolically most FDG-PET avid part of the tumour. Hereby, a biologicall...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Heukelom, Jolien, Hamming, Olga, Bartelink, Harry, Hoebers, Frank, Giralt, Jordi, Herlestam, Teresa, Verheij, Marcel, Brekel, Michiel van den, Vogel, Wouter, Slevin, Nick, Deutsch, Eric, Sonke, Jan-Jakob, Lambin, Philippe, Rasch, Coen
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599345/
https://ncbi.nlm.nih.gov/pubmed/23433435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-84
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items